Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in JNJ — Johnson & Johnson

CIK 1452765 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,550,994
-$1,375,441 QoQ
Shares Held
6,107
-49.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,571
of 4,664 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Sep 30, 2024
CallValue
$32,136,498
CallShares
198,300
PutValue
$28,084,998
PutShares
173,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $12,976,736 across 10 Drug Manufacturers - General names. JNJ ranks #4 (12.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 JNJ
Johnson & Johnson
This page
6,107 $1,550,994

All Filings in JNJ

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,550,994 6,107
2026-03-31 $2,926,435 11,972
2025-12-31 $6,990,771 33,780
2025-09-30 $2,128,621 11,480
2025-06-30 $1,236,053 8,092
2025-03-31 $1,981,456 11,948
2024-12-31 $2,099,882 14,520
2024-09-30 $32,136,498 198,300
2024-09-30 $28,084,998 173,300
2024-09-30 $2,351,328 14,509
2024-06-30 $28,778,904 196,900
2024-06-30 $22,903,272 156,700
2024-06-30 $6,934,415 47,444
2024-03-31 $62,485,050 395,000
2024-03-31 $558,727 3,532
2024-03-31 $37,696,677 238,300
2023-12-31 $58,275,932 371,800
2023-12-31 $34,310,386 218,900
2023-12-31 $9,589,196 61,179
2023-09-30 $60,197,375 386,500
2023-09-30 $13,430,011 86,228
2023-09-30 $59,870,300 384,400
2023-06-30 $24,321,508 146,940